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Introduction
Flat panel detector (FD) equipped angiography machines are increasingly being used for neuro-angiographic imaging [1] [2] [3] [4] and it is now possible to obtain high-quality 3-dimensional (3D) vascular images with cone-beam computed tomography (CBCT). 3 Neuro-endovascular treatment outcomes have improved, due to advances in interventional techniques and devices; [5] [6] [7] however, the latest procedures have also become more complex. As a result, fluoroscopy time and the number of acquisitions have increased for digital subtraction angiography (DSA) and CBCT, and the patient's radiation exposure doses are also higher. 8 This is especially true for intracranial stentassisted coil embolization procedures, for which it is very important to visualize stent shape after deployment in the vessel. 9, 10 An intracranial stent has four proximal and distal radiopaque markers and is hardly visible with 1 Division of Radiological Technology, Institute of Biomedical Research and Innovation, Kobe, Japan 2 Division of Neuroendovascular Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan current standard techniques, such as digital radiography and fluoroscopy. 9, 11 Therefore, it is important to quickly visualize stents by CBCT 12 so that the surgeon can start treatment, after confirming the appropriate stent localization in the vessel. 13 The aim of the present study was to compare the utility of 10 s and 20 s duration of CBCT for obtaining high-quality images to guide neuro-endovascular treatment procedures.
Patients and methods

CBCT procedure
CBCT acquisitions were performed using a biplane FD angiographic system (Artis zee BA Twin, Siemens AG, Forchheim, Germany) and commercially available software (syngo DynaCT, Siemens AG, Forchheim, Germany). The motorized frontal C-arm, typically used for 3D rotational angiography, was used to acquire 250 or 500 projection images over a 200 arc, with a rotation time of 10 s or 20 s, respectively. [1] [2] [3] [4] We calculated a volume of interest using rotational acquisition over an angular range of about 200 . Table 1 shows the CBCT acquisition protocols that were used to obtain a series of 2-dimensional (2D) projection images or 'frames' that were then reconstructed, using a CT-like algorithm to create a 3D volume that was post-processed for visualization and analysis, similar to conventional multi-section CT images.
Post-processing was performed with a separate workstation (syngo X-Workplace, Siemens AG, Forchheim, Germany). The software includes application of system-specific filter algorithms to correct for beam hardening, scattered radiation, truncated projections and ring artifacts. It allows the use of different algorithms, so that reconstructions can be done of only the fill run. CBCT by 2 Â 2 binning was performed using a program with a single rotation time of 10 s or 20 s in the full acquisition run (contrast medium injection time, 14.5 s or 24.5 s, respectively; x-ray delay time, 4.5 s). For image analysis, the volumetric data were loaded into the 3D application, to create 3D-maximum intensity projections (MIPs). Secondary calculations of image data were performed with a volume of approximately 7.5 cm Â 7.5 cm Â 7.5 cm and a 512 Â 512 matrix, which yielded an isotropic voxel size of 0.15 mm. The 3D-MIP reconstructions of each aneurysm were generated in an oblique orientation, with a 1.5-mm section thickness.
Stent visualization in the phantom
Stent visualization was assessed by generating MIPs for the 10 s and 20 s CBCTs. The phantom comprised a stent and diluted contrast medium in a syringe, set up on the bed. We employed the latest generation of intracranial self-expandable, closed-cell design stents (Enterprise Vascular Reconstruction Device microdelivery stent systems, Johnson and Johnson, New Brunswick, NJ, USA). The contrast medium (Iopamidol 300, Bayer HealthCare, Osaka, Japan) was diluted with saline to approximately 14% (10 mL contrast þ 60 mL saline). A resolution of a stent strut analyze stent strut using linear line by the full width at half maximum (FWHM) 14 which is more commonly used as the spatial resolution. It measured five times, and demanded the mean (SD). We compared to 10 s and 20 s CBCTs with the FWHM of stent strut. The MIP images were 10 times the size, for easy measurement.
Patients
We selected 30 consecutive patients (9 male and 21 female, 33-84 years old, mean age 62 years) with 30 unruptured intracranial aneurysms (22 and 8 were found in the anterior and posterior circulation, respectively) that were treated with stent-assisted coil embolization between June and December 2014. We imaged 16 and 14 patients with either the 10 s or 20 s CBCT, respectively. Wide-necked intracranial aneurysms were treated with stents followed by aneurysm embolization using platinum coils. Just after deployment, stent images were acquired by 10 s or 20 s CBCTs. Table 2 lists the proximal and distal vessel diameters 3.0 mm from the aneurysm neck before stent deployment. The diluted contrast medium mixed with saline was injected into a catheter at a rate of 1.0 mL/s with a single-power injector (Press pro, Nemoto Co., Tokyo, Japan). The contrast medium volumes were 15 or 25 mL for the 10 s or the 20 s CBCT, respectively. Because of the limited speed of gantry movement, CBCT can only be obtained with a contrast medium injection protocol that generates a steady state of contrast medium in the intracranial vessel and aneurysm during acquisition. Therefore, we 
Statistics
CBCT data were downloaded to a personal computer in DICOM format. The image processing was performed using Image J version 1.43 (National Institutes of Health, Bethesda, MD, USA). Statistical analysis was performed using Excel (Microsoft, Redmond, WA, USA). We calculated the mean (SD) for each dimension.
To assess correlations between the variables, linear twosided correlation t-tests were performed. Differences were considered significant at p < 0.05. 
Results
Stent visualization in the phantom
Patients
Stent deployment was safely achieved at the desired location in all 30 patients. MIPs were generated from the 10 s or 20 s CBCT scans, performed after stent deployment to visualize the neck plane or clipped image (1.5 mm thickness by barrel view). The images showed excellent stent visibility and regular, complete stent deployment. Both CBCT techniques seemed to provide nearly identical images of the stent in the clinical cases. Figure 2 and Figure 3 contain MIPs showing the outside of the stent and coils with cut clip function. The 3D-fusion MIP image was taken with a 1.5 mm section thickness from a barrel view, to observe the relationship between the stent and coil package ( Figure 2 and the second Figure 3 (f)). The DAP values for the 10 s and 20 s CBCTs were 2248 AE 304 and 3843 AE 702 mGy Â mm 2 , respectively (p < 0.05). The corresponding minimums and maximums were 1624-2676 mGy Â mm 2 and 2464 and 5066 mGy Â mm 2 .
Discussion
Visualization of stent in the phantom
As 10 s CBCTs requires one-half the projections of 20 s CBCTs, they may therefore produce blurrier images. Figure 1 (c) shows the contrast value and FWHMs for both methods, and the 10 s/20 s CBCT ratios of contrast value were 0.69 and 1.15, respectively. Compared with a 20 s CBCT, our experimental protocol had a low contrast value that produced an image with a wider WW and lower WC; however, the 10 s CBCT was 1.15 times blurrier by FWHM, compared with the 20 s CBCT, and the image was more difficult to adjust. Saake et al. 15 report that the cerebral vasculature can be visualized with 10 s FD-CTA at high resolution, in many vessel segments; this modality is comparable to DSA. Struffert 16 reports that 10 s FD-CTA could clearly visualize the stent and lumen. In an in vivo model, Ebrahimi et al. 17 report that 10 s CBCT is superior to DSA and DR, in visualizing small metallic stents, and enables accurate detection of adverse stent mechanics; however Ionescu et al. 18 report that the combination of improved spatial resolution and better software and hardware for image post-processing will be necessary for detailed structural analysis.
The acquisition time for 10 s CBCT is shorter than that of 20 s CBCT, and reconstruction time can also be shorter, which might be especially helpful in stent-assisted coil embolization. Now that 10 s CBCT has been shown to be comparable with 20 s CBCT, it can be used to predict the stability of stent-treated aneurysms.
Patients
Our results show that the 10 s CBCT allows sufficient visualization to check for kinks and verify stent expansion. We speculate that using this protocol reduces radiation exposure by approximately 42%, compared to the 20 s CBCT, as the number of projections is calculated to decrease from 1532 to 1016. We therefore feel that our study is potentially clinically relevant for treatments such as Pipeline stents. Several 10 s CBCT protocols are available, but need to be further developed to demonstrate that stent visualization can be achieved with lower radiation exposure. Another advantage of 10 s CBCT is the potential reduction in contrast medium (24.5 mL versus 14.5 mL). In general, the relationship between stents and aneurysm visualization depends on the amount of contrast medium. It is important to note that the ability to perform 10 s CBCT is restricted to stent-assisted coil embolization.
The 20 s CBCT provides high-quality stent images. Even the strut is visible on the 3D-MIPs, 19 and it is considered the gold standard for aneurysm evaluation. 20, 21 Overall, this might result in more precise visualization. In Figure 2 and Figure 3 , the second (e) panel shows that even incomplete stent deployment or deficient fitting to the vessel wall may remain unnoticed. Its feasibility concerning stent and vessel/aneurysm visualization has been clinically demonstrated, but it may be appropriate to make 10 s CBCT the next standard for stent visualization, as it provides a good overview of stent position and deployment with diluted contrast.
In 20 s CBCT, the combination of high spatial resolution and intra-arterial administration of the diluted contrast medium compensates for the lower contrast resolution and provides clear views of the stent and detailed vascular anatomy. 9,10 CBCT images are susceptible to noise, scatter, partial volume effects, truncation artifacts, beam hardening, ring artifacts and motion artifacts. Several algorithms have been developed to reduce noise and motion artifacts during reconstruction, or to modify the x-ray spectrum. 22, 23 The cardiac beat is particularly problematic in CBCT imaging of the cerebral vasculature, because any motion strongly degrades image quality with streaking and blurring, especially when the diluted contrast medium is injected. All relevant factors should be considered when justifying the selection of these techniques. 24 One positive aspect of the 20 s versus 10 s duration of treatment is that the higher number of projections provides higher spatial resolution, but introduces more motion artifacts. In this study, the FWHM of 10 s CBCT images was 1.15 times blurrier than the 20 s CBCT images; however, the radiation dose was reduced by approximately 42%. It is important to optimize the balance between minimizing radiation dose and achieving good image quality. The limitations of our study include a small number of clinical cases and the lack of image quality analysis. Prospective studies with stricter criteria for patient selection are needed, to evaluate the MIP image quality of 10 s CBCTs.
In conclusion, we compared 10 s and 20 s CBCTs, and confirmed that the shorter rotation time provides acceptable stent images using FWHM in patients with aneurysms. Notably, the 10 s CBCTs reduced the radiation exposure dose by approximately 42%. The ability of 10 s CBCT to use a 14% dilution of contrast medium may significantly improve image acquisition during stent-assisted coil embolization. Future investigations should be performed so that this protocol can be developed for neuro-endovascular procedures.
